IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

NCT00747604 · clinicaltrials.gov ↗

TERMINATED

Status

1378

Enrollment

INDUSTRY

Sponsor class

Stopped Shortage of Increlex supply

Conditions

Primary Insulin-like Growth Factor-1 Deficiency

Interventions

BIOLOGICAL: mecasermin [rDNA origin] injection

Sponsor

Ipsen